19 min listen
Inside the arms race to develop new psychedelic drugs
FromThe Big Story
ratings:
Length:
23 minutes
Released:
Aug 11, 2022
Format:
Podcast episode
Description
There's a lot of money in creating and patenting new drugs. Like, tens of billions of dollars. But the field is crowded, competitive and dominated by large pharmaceutical companies. So some new startups are looking elsewhere.For decades psychedelics have been illegal, taboo and largely considered the drugs of hippies. The past decade, though, has changed that, as psilocybin, ketamine and others have been increasingly used therapeutically. So now the race is on to create brand new psychedelics, that can be approved, patented and ... yup, marketed to you. Welcome to the psychedelic arms race.GUEST: John Semley, writer and researcher (Read John's piece in WIRED, right here.)
Released:
Aug 11, 2022
Format:
Podcast episode
Titles in the series (100)
Why a no-fly zone won't happen, and what comes next in Ukraine?: It's been one request that absolutely nobody is willing to grant. While many NATO members are sending arms and aid to Ukrainians, President Volodymyr Zelenskyy's pleas for a no-fly zone over his country have been rebuffed. And there's a good reason for that. Today: How a no-fly zone works, why allies are refusing to enact one and what happens next in Ukraine, where Russian forces continue to increase the destructiveness of their attacks... GUEST: Abbie Shull, junior military and defense reporter at Business Insider by The Big Story